Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, 30130-100, Brazil
NCT Number: NCT05660928
Hypertension and diabetes mellitus (DM) are highly prevalent in low and middle-income countries, and the proportion of patients with uncontrolled diseases is higher than in high income countries. Innovative strategies are required to surpass barriers of low sources, distance, and quality of healthcare. Our aim is to assess the uptake and effectiveness of the implementation of an integrated multidimensional strategy in the primary care setting, for the management of patients with hypertension and diabetes mellitus (DM) in Brazil. This is a scale up implementation study that has mixed-methods, and comprehends four steps: (1) needs assessment, including a standardized structured questionnaire and focus groups with healthcare practitioners; (2) baseline period, three months before the implementation of the intervention; (3) cluster randomized controlled trial (RCT) with a 12-month follow-up period; and (4) a qualitative study after the end of follow-up. The cluster RCT will randomize 35 centres to intervention (n= 18) or usual care (n= 17). Patients ≥18 years-old, with diagnosis of hypertension and/or DM, of five Brazilian cities in a resource-constrained area will be enrolled. The intervention consists of a multifaceted strategy, with a multidisciplinary approach, including telehealth tools (decision support systems, short message service, telediagnosis), continued education with an approach to issues related to the care of people with hypertension and diabetes in primary care, including pharmacological and non-pharmacological treatment and behavioural change. The project has actions focused on professionals and patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Belo Horizonte, Minas Gerais, 30130-100, Brazil
This scale up implementation study has mixed-methods, and comprehends four steps: (1) needs assessment, (2) baseline period, (3) cluster RCT and (4) qualitative study. The RE-AIM planning and evaluation framework will be used in this research project, which includes: reach (R), efficacy (E), adoption (A), implementation (I), and maintenance (M). The Adaptation Framework might be used as well, in case adaptations need to be conducted during the intervention, taking into account the COVID-19 pandemic and possible new waves.
To calculate the sample size, the investigators took into account the proportion of patients with controlled hypertension (33%) and DM (37%) observed at baseline in the pilot study (data not published), and an absolute increase of 6% in these proportions one year after the implementation of the intervention, with a power of 0.80, level of significance of 0.05 and intra cluster correlation coefficient of 0.026. The calculated sample was 34 primary care centres, 17 in each arm, with a minimum of 148 participants in each centre. As the total number of primary care centres in the five municipalities is 35, the investigators planned to include one extra unit in the intervention arm. Taking into account a drop out rate of up to 17.8%, the total number of included individuals will be 180.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Primary Health Care - Basic health unit with internet availability and complete team, including a Brazilian doctor or with a proficiency test in the Portuguese language.
Patients
Subproject cluster randomised controlled trial. All of the above criteria and the following additional criteria:
Exclusion criteria
Multidimensional intervention, with mutidisciplinary approach.
Time frame: 12 months
(i) for hypertension, the proportion (%) of patients with systolic blood pressure (SBP) <140 mmHg and diastolic blood pressure (DBP) < 90 mmHg; (ii) for diabetes, the proportion (%) of patients with glycohemoglobin ≤ 7% if the age < 60 years, or < 8% if the age is ≥ 60 years; (iii) for those with both hypertension and diabetes, proportion (%) of patients with both diseases controlled.
Time frame: 12 months
The proportion (%) of patients with systolic blood pressure (SBP) <140 mmHg and diastolic blood pressure (DBP) < 90 mmHg
Time frame: 12 months
The proportion (%) of patients with glycohemoglobin ≤ 7% if the age < 60 years, or < 8% if the age is ≥ 60 years
Time frame: 12 months
The mean difference in delta SBP and DBP (mmHg) in patients with hypertension, when comparing the intervention and the control groups, in 12 months
Time frame: 12 months
The mean difference in delta glycohemoglobin (%) in patients with diabetes, when comparing the intervention and the control groups, in 12 months
Time frame: 12 months
Number of blood pressure measurements per patient with hypertension in 12 months
Time frame: 12 months
Number of glycohemoglobin measurements per patient with diabetes in 12 months
Time frame: 12 months
Percentage of patients with hypertension and diabetes who participated at least once in group activities in 12 months.
Time frame: 12 months
Time in months between the first consultation after enrollment and last consultation during the study period
Time frame: 12 months
Number of consultations with medical doctors and nurses during the follow-up time
Time frame: 6 and 12 months
The difference in the number of steps (delta from the beginning) in the 2-minute standing gait test within 6 months and 12 months.
Time frame: 6 and 12 months
The difference in the hand grip strength measured by in kgf (delta from the beginning) within 6 months and 12 months.
Time frame: 12 months
The change in the body weight (kg) in the follow-up time
Time frame: 12 months
The change in the body mass index in the follow-up time
Time frame: 12 months
The change in the waist circumference (cm) in the follow-up time
Time frame: 12 months
Total follow-up time (time between the first consultation after enrollment and last consultation); median time between medical and nurse consultations; number of consultations during follow-up time, number of groups conducted at each primary care centre during the follow-up; participation of patients at the educational groups; adherence to CDSS recommendations (intervention group only).
Federal University of Minas Gerais
Other
Control of Hypertension and diAbetes in MINas Gerais: Assessment of the Impact of Implementing a Multidimensional Strategy for Management of Patients With Systemic Arterial Hypertension and Diabetes Mellitus in Primary Care
Acronym: CHArMING
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03539627
Angina Pectoris, Angina, Stable
Kemerovo, Russia
View Trial DetailsNCT03049709
Arterial Hypertension, Cardiovascular Diseases
Mannheim, Germany
View Trial DetailsNCT01117831
Arterial Hypertension, Cardiovascular Diseases
View Trial DetailsNCT02041832
Arterial Hypertension, Cardiovascular Diseases
Haderslev, Denmark
View Trial Details